Determination of tegafur, 5-fluorouracil, gimeracil and oxonic acid in human plasma using liquid chromatography-tandem mass spectrometry.
暂无分享,去创建一个
Ke Liu | Dafang Zhong | Xiaoyan Chen | D. Zhong | Ke-Shun Liu | Xiaoyan Chen | Huiyu Zou | H. Zou
[1] Xiaoyan Chen,et al. Derivatization of beta-dicarbonyl compound with 2,4-dinitrophenylhydrazine to enhance mass spectrometric detection: application in quantitative analysis of houttuynin in human plasma. , 2008, Journal of mass spectrometry : JMS.
[2] E. Bush,et al. Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry , 1998, Journal of the American Society for Mass Spectrometry.
[3] M. Boisdron-Celle,et al. Sensitive MS/MS-liquid chromatography assay for simultaneous determination of tegafur, 5-fluorouracil and 5-fluorodihydrouracil in plasma. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[4] Vinod P. Shah,et al. Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays , 2007, The AAPS Journal.
[5] L. Wise,et al. Measurement of 5-fluorouracil and its active metabolites in tissue. , 1990, Journal of chromatography.
[6] T. Kubota. The role of S-1 in the treatment of gastric cancer , 2008, British Journal of Cancer.
[7] M. Barberi-Heyob,et al. Analysis of 5-fluorouracil in plasma and urine by high-performance liquid chromatography. , 1992, Journal of chromatography.
[8] M. Fukushima,et al. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. , 1993, Cancer research.
[9] F. D. Boudinot,et al. High-performance liquid chromatographic determination of 5-fluorouracil and its prodrugs, tegafur and 4-deoxy-5-fluorouracil, in rat plasma. , 1996, Journal of chromatography. B, Biomedical applications.
[10] T. Shirasaka. Development History and Concept of an Oral Anticancer Agent S-1 (TS-1®): Its Clinical Usefulness and Future Vistas , 2008, Japanese journal of clinical oncology.
[11] G. Weber,et al. Purification and properties of dihydrothymine dehydrogenase from rat liver. , 1981, The Journal of biological chemistry.
[12] M. Fukushima,et al. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extracts. , 1987, Japanese journal of cancer research : Gann.
[13] M. Slavik,et al. Analysis of 5-flourouracil in plasma by precolumn derivatization with 4-bromomethyl-7-methoxycoumarin, followed by multi-dimensional high-performance liquid chromatography , 1989 .
[14] J. Strong,et al. Gas chromatographic-mass spectrometric method for routine monitoring of 5-fluorouracil in plasma of patients receiving low-level protracted infusions. , 1992, Journal of chromatography.
[15] D. Watson,et al. The analysis of 5-fluorouracil in human plasma by gas chromatography-negative ion chemical ionization mass spectrometry (GC-NICIMS) with stable isotope dilution. , 1991, Journal of pharmaceutical and biomedical analysis.
[16] J. Gu,et al. Sensitive liquid chromatographic assay for the simultaneous determination of 5-fluorouracil and its prodrug, tegafur, in beagle dog plasma. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] S. Hirose,et al. Use of 4-bromomethyl-7-methoxycoumarin for derivatization of pyrimidine compounds in serum analysed by high-performance liquid chromatography with fluorimetric detection. , 1986, Journal of chromatography.
[18] E. Matsushima,et al. Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometry. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[19] P. Ueland,et al. Uracil in human DNA from subjects with normal and impaired folate status as determined by high-performance liquid chromatography-tandem mass spectrometry. , 2002, Analytical chemistry.
[20] H. Sasabe,et al. Highly sensitive method for the determination of 5-fluorouracil in biological samples in the presence of 2'-deoxy-5-fluorouridine by gas chromatography-mass spectrometry. , 1991, Journal of chromatography.
[21] J. van der Greef,et al. Reversed-phase ion-pair analysis of 5-fluorouracil in pig bile, liver homogenate, plasma and urine after administration by isolated liver perfusion. , 1989, Journal of pharmaceutical and biomedical analysis.
[22] Vinod P. Shah,et al. Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.
[23] L. Zufía,et al. Determination of 5-Fluorouracil and Its Prodrug Tegafur in Plasma and Tissue by High-Performance Liquid Chromatography in a Single Injection: Validation for Application in Clinical Pharmacokinetic Studies , 2003, Therapeutic drug monitoring.
[24] P. Zambonin,et al. Solid-phase extraction of fluoropyrimidine derivatives on a copper-modified strong cation exchanger: determination of doxifluridine, 5-fluorouracil and its main metabolites in serum by high-performance liquid chromatography with ultraviolet detection. , 1993, Journal of chromatography.
[25] D. Massart,et al. Determination of leucovorin and 5-fluorouracil in plasma by high-performance liquid chromatography. , 1993, Journal of chromatography.